MARKHAM, Ontario--(BUSINESS WIRE)--Exact Imaging today announced results from its OPTIMUM clinical trial demonstrating the non-inferiority of its ExactVu™ micro-ultrasound platform to MRI ...

A combined PSMA-PET/MRI scanner better detected clinically significant prostate cancer in men on active surveillance. The addition of piflufolastat F18 (18 F-DCFPyL) prostate-specific membrane antigen ...

A nationwide survey of prostate MRI practices in the UK revealed the universal adoption of pre-biopsy MRI across all NHS trusts, with 73.1% using multiparametric MRI protocols. However, significant ...